FDA Seeks OMB Clearance for Medical Device Adverse Event Reporting Program (MedSun)
FDA's submission of the MedSun information collection for OMB review signals continued focus on post-market surveillance of medical devices through structured adverse event reporting. The Food and Drug Administration has submitted a proposed information collection request to the Office of...